A Human Primary Skin Irritation Safety Evaluation of CURECODE Neuromide Ampoule

A Human Skin Primary Irritation Test of CURECODE Neuromide Ampoule

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011507

Enrollment

Registered

2026-01-21

Start date

2024-12-09

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Cosmetic product) : The test product, CURECODE Neuromide Ampoule, was applied once to the skin of the upper back of the subjects under occlusive patch conditions. After patch removal, skin reac

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male or female adults aged between 20 and 60 years 2. Subjects with healthy skin and no dermatological disorders or lesions at the test site (upper back) 3. Subjects who voluntarily provided written informed consent after receiving a full explanation of the study 4. Subjects able to comply with the study procedures and instructions during the study period

Exclusion criteria

Exclusion criteria: 1. Subjects with skin diseases, wounds, inflammation, infection, or hypersensitivity at the test site 2. Subjects with a known history of hypersensitivity or allergic reactions to cosmetic products or ingredients 3. Subjects who received topical medication or dermatological treatment on the test site within two weeks prior to the study 4. Pregnant or breastfeeding women 5. Subjects deemed unsuitable for participation by the investigator

Design outcomes

Primary

Measure	Time frame
Degree of primary skin irritation following application of the test product	—

Secondary

Measure	Time frame
Occurrence of adverse events related to the test product during the study period	—

Countries

Korea, Republic of

Contacts

Public ContactMin youl Change

SKINMED

mychang195@gmail.com+82-70-5118-8404

Outcome results